SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 26 filers reported holding SILENCE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,516,000 | -39.5% | 634,270 | -3.0% | 31.70% | +50.3% |
| Q1 2022 | $12,428,000 | -31.4% | 654,108 | -13.7% | 21.08% | +78.4% |
| Q4 2021 | $18,115,000 | +385.8% | 758,253 | +324.1% | 11.82% | +478.9% |
| Q3 2021 | $3,729,000 | -35.5% | 178,787 | -19.5% | 2.04% | +193.7% |
| Q2 2021 | $5,779,000 | +13.1% | 222,222 | 0.0% | 0.70% | +27.5% |
| Q1 2021 | $5,111,000 | – | 222,222 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 634,270 | $7,516,000 | 31.70% |
| Lombard Odier Asset Management (USA) Corp | 3,766,369 | $38,166,000 | 1.47% |
| GREAT POINT PARTNERS LLC | 401,449 | $4,757,000 | 1.14% |
| Frazier Life Sciences Management, L.P. | 881,173 | $10,442,000 | 0.98% |
| Deep Track Capital, LP | 951,580 | $11,276,000 | 0.74% |
| BVF INC/IL | 666,666 | $7,900,000 | 0.38% |
| Parkman Healthcare Partners LLC | 26,250 | $311,000 | 0.12% |
| CANTOR FITZGERALD, L. P. | 211,460 | $2,506,000 | 0.05% |
| AXA S.A. | 1,283,332 | $15,207,742 | 0.03% |
| WS MANAGEMENT LLLP | 25,000 | $296,000 | 0.02% |